Patients see potential benefits from direct-to-consumer genetic testing, but are also concerned about how the test results will be used, and generally are unwilling to pay more than $10 or $20 for them, according to focus groups conducted by researchers at Loyola University Chicago Stritch School of Medicine. Findings by first author Katherine Wasson, PhD, MPH, and colleagues are published in the American Journal of Bioethics Primary Research...
More...
More...